1.Jaffe-Campanacci syndrome: report of a case.
Yu-hua ZHOU ; Li-rong BI ; Jing-bo WANG ; Yin-ping WANG ; William ORR
Chinese Journal of Pathology 2011;40(6):409-409
Bone Neoplasms
;
diagnosis
;
diagnostic imaging
;
pathology
;
Cafe-au-Lait Spots
;
diagnosis
;
pathology
;
Child
;
Diagnosis, Differential
;
Female
;
Fibroma
;
diagnosis
;
diagnostic imaging
;
pathology
;
Humans
;
Neurofibromatosis 1
;
diagnosis
;
Radiography
;
Syndrome
2.Impact of Sleep Dysfunction on Anorectal Motility in Healthy Humans.
Tso Tsai LIU ; Chih Hsun YI ; Chien Lin CHEN ; William C ORR
Journal of Neurogastroenterology and Motility 2011;17(2):180-184
BACKGROUND/AIMS: Sleep dysfunction is associated with altered gastrointestinal function and subsequently exacerbations of gastrointestinal problems. We aimed to investigate whether sleep dysfunction would influence anorectal motility as determined by anorectal manometry. The effect of anxiety on anorectal motility was also determined. METHODS: A total of 24 healthy volunteers underwent anorectal manometry. The anorectal parameters included resting and squeeze sphincter pressure, sensory thresholds in response to balloon distension, sphincter length, rectal compliance, and rectoanal inhibitory reflex. Sleep dysfunction was subjectively assessed by using Pittsburgh Sleep Quality Index (PSQI). Anxiety was assessed by the application of the State-Trait Anxiety Inventory questionnaire. RESULTS: There were sixteen subjects without sleep dysfunction (7 women; mean age, 22 years) and eight subjects with sleep dysfunction (2 women; mean age, 22 years). There was no group difference in the volume threshold for rectoanal inhibitory reflux, rectal compliance or sphincter length (P = NS). Anal sphincter pressure did not differ between the groups (P = NS). The rectal sensitivity for different levels of stimulation did not differ between the groups (P = NS). Sleep quality as determined by PSQI correlated with rectal compliance (r = 0.66, P = 0.007). Although there was no differences in any manometric parameters between subjects with and without anxiety, the anxiety score correlated with rectal compliance (r = 0.57, P = 0.003). CONCLUSIONS: Despite a positive association between rectal compliance and the level of subjective sleep or anxiety, sleep dysfunction did not apparently affect most of anorectal function in healthy subjects, nor did anxiety.
Anal Canal
;
Anxiety
;
Compliance
;
Humans
;
Manometry
;
Reflex
;
Sensory Thresholds
3.Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group.
Juan Carlos LOPEZ-ALVARENGA ; William ORR ; Jose Antonio VARGAS-ROMERO ; Jose Maria REMES-TROCHE ; Miguel MORALES-ARAMBULA ; Julio Cesar SOTO-PEREZ ; Gualberto MATEOS-PEREZ ; Sergio SOBRINO-COSSIO ; Oscar TERAMOTO-MATSUBARA ; Aurelio LOPEZ-COLOMBO ; Antonio OROZCO-GAMIZ ; Adolfo SAEZ-RIOS ; Araceli ARELLANO-PLANCARTE ; Jazmin CHIU-UGALDE ; Anne THOLEN ; Silke HORBACH ; Lars LUNDBERG ; Ronnie FASS
Journal of Neurogastroenterology and Motility 2014;20(1):64-73
BACKGROUND/AIMS: To evaluate the effectiveness of pantoprazole magnesium (pantoprazole-Mg) 40 mg in the relief of esophageal and extra-esophageal symptoms of gastroesophageal reflux disease (GERD), particularly night-time symptoms. METHODS: Patients (aged 18-50 years) with 3-month history of heartburn and/or acid regurgitation plus at least one other symptom in the last week were enrolled in a nationwide, prospective and observational study in Mexico. Patients received pantoprazole-Mg 40 mg once daily during 4 weeks. Symptoms were assessed through a physician-administered structured interview and the patient-completed ReQuest in Practice(TM) questionnaire. Night-time GERD was defined as arousal from sleep during the night due to GERD-associated symptoms. RESULTS: Out of 4,343 patients included at basal visit, 3,665 were considered for the effectiveness per protocol analysis. At baseline, patients had a median of 8 GERD related symptoms. Patients with night-time GERD symptoms (42.7%) were more likely to have extra-esophageal symptoms (P < 0.001) than other GERD patients. Pantoprazole-Mg 40 mg once daily for 4 weeks improved a broad range of GERD-associated symptoms from baseline (80% reduction on physicians assessments; 68-77% reduction on ReQuest in Practice(TM) dimensions), including both day- and night-time GERD symptoms; improvements were the greatest for extra-esophageal symptoms in patients with night-time symptoms. Pantoprazole-Mg was well tolerated. CONCLUSIONS: Pantoprazole-Mg 40 mg significantly improved a broad range of esophageal and extra-esophageal GERD related symptoms including sleep disturbances, as well as well-being, in patients with daytime or night-time GERD, making it a good option for patients with GERD, especially when extra-esophageal and night-time symptoms are present.
Arousal
;
Gastroesophageal Reflux*
;
Heartburn
;
Humans
;
Magnesium*
;
Mexico
;
Observational Study
;
Prospective Studies
;
Proton Pump Inhibitors
;
Surveys and Questionnaires